nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—ALB—membranous glomerulonephritis	0.959	1	CbGaD
Valsartan—SLCO1B3—Transport of organic anions—ALB—membranous glomerulonephritis	0.00221	0.0537	CbGpPWpGaD
Valsartan—SLCO1B3—Recycling of bile acids and salts—ALB—membranous glomerulonephritis	0.00164	0.0398	CbGpPWpGaD
Valsartan—SLCO1B1—Transport of organic anions—ALB—membranous glomerulonephritis	0.00148	0.0361	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PLG—membranous glomerulonephritis	0.00136	0.0331	CbGpPWpGaD
Valsartan—ALB—HDL-mediated lipid transport—ABCA1—membranous glomerulonephritis	0.00128	0.0312	CbGpPWpGaD
Valsartan—SLCO1B1—Recycling of bile acids and salts—ALB—membranous glomerulonephritis	0.0011	0.0267	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—CD40—membranous glomerulonephritis	0.00106	0.0257	CbGpPWpGaD
Valsartan—ALB—Scavenging of heme from plasma—APOA1—membranous glomerulonephritis	0.000937	0.0228	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—HLA-DQA1—membranous glomerulonephritis	0.000919	0.0223	CbGpPWpGaD
Valsartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—membranous glomerulonephritis	0.000856	0.0208	CbGpPWpGaD
Valsartan—ALB—HDL-mediated lipid transport—APOE—membranous glomerulonephritis	0.000845	0.0205	CbGpPWpGaD
Valsartan—ALB—HDL-mediated lipid transport—APOA1—membranous glomerulonephritis	0.000835	0.0203	CbGpPWpGaD
Valsartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—membranous glomerulonephritis	0.00082	0.0199	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—CD40LG—membranous glomerulonephritis	0.000812	0.0197	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—LRP2—membranous glomerulonephritis	0.000749	0.0182	CbGpPWpGaD
Valsartan—ALB—Lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.000738	0.0179	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—C3—membranous glomerulonephritis	0.000717	0.0174	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—membranous glomerulonephritis	0.000705	0.0171	CbGpPWpGaD
Valsartan—CYP2C9—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.000699	0.017	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.000653	0.0159	CbGpPWpGaD
Valsartan—CYP2C9—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.000604	0.0147	CbGpPWpGaD
Valsartan—SLCO1B1—Bile acid and bile salt metabolism—ALB—membranous glomerulonephritis	0.000575	0.014	CbGpPWpGaD
Valsartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—membranous glomerulonephritis	0.000551	0.0134	CbGpPWpGaD
Valsartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.000546	0.0133	CbGpPWpGaD
Valsartan—ALB—Lipid and lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.00049	0.0119	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00049	0.0119	CbGpPWpGaD
Valsartan—ALB—Lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000485	0.0118	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—ABCA1—membranous glomerulonephritis	0.000483	0.0117	CbGpPWpGaD
Valsartan—ALB—Lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.00048	0.0117	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—PLG—membranous glomerulonephritis	0.000449	0.0109	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.000426	0.0104	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—SPARC—membranous glomerulonephritis	0.000413	0.01	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—membranous glomerulonephritis	0.000393	0.00957	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—ABCA1—membranous glomerulonephritis	0.000393	0.00955	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—membranous glomerulonephritis	0.000378	0.00919	CbGpPWpGaD
Valsartan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—membranous glomerulonephritis	0.000374	0.00909	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—PLG—membranous glomerulonephritis	0.000365	0.00888	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.000355	0.00864	CbGpPWpGaD
Valsartan—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—membranous glomerulonephritis	0.000353	0.00859	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000341	0.00828	CbGpPWpGaD
Valsartan—ALB—Lipid and lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000323	0.00784	CbGpPWpGaD
Valsartan—ALB—Lipid and lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.000319	0.00775	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000318	0.00773	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—APOE—membranous glomerulonephritis	0.000317	0.00772	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—APOA1—membranous glomerulonephritis	0.000314	0.00763	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—PLG—membranous glomerulonephritis	0.000313	0.00761	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.000312	0.00759	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—PLG—membranous glomerulonephritis	0.000298	0.00725	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.00029	0.00705	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000283	0.00689	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000273	0.00663	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00026	0.00632	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—APOA1—membranous glomerulonephritis	0.000255	0.00621	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.000238	0.0058	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—APOA1—membranous glomerulonephritis	0.000219	0.00532	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000214	0.00519	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—membranous glomerulonephritis	0.000209	0.00507	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.000203	0.00493	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL1B—membranous glomerulonephritis	0.000202	0.00492	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00019	0.00463	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000183	0.00445	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SPARC—membranous glomerulonephritis	0.000183	0.00445	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000183	0.00444	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—C3—membranous glomerulonephritis	0.000182	0.00441	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.000176	0.00428	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL1B—membranous glomerulonephritis	0.000165	0.004	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000161	0.00392	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TBXAS1—membranous glomerulonephritis	0.000142	0.00344	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PLG—membranous glomerulonephritis	0.000139	0.00338	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000131	0.00318	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—LRP2—membranous glomerulonephritis	0.000126	0.00307	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000123	0.00298	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000122	0.00297	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000121	0.00295	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000121	0.00294	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.00012	0.00292	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000119	0.00289	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.000118	0.00287	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000113	0.00274	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000109	0.00264	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000108	0.00264	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000105	0.00255	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—C3—membranous glomerulonephritis	0.000103	0.00249	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	9.99e-05	0.00243	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—APOA1—membranous glomerulonephritis	9.71e-05	0.00236	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TBXAS1—membranous glomerulonephritis	9.51e-05	0.00231	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SPARC—membranous glomerulonephritis	9.44e-05	0.0023	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	9.4e-05	0.00229	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—C3—membranous glomerulonephritis	9.32e-05	0.00227	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	8.94e-05	0.00217	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	8.9e-05	0.00216	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	8.57e-05	0.00208	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LRP2—membranous glomerulonephritis	8.48e-05	0.00206	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLA2G1B—membranous glomerulonephritis	8.16e-05	0.00198	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCA1—membranous glomerulonephritis	8.13e-05	0.00198	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	8.07e-05	0.00196	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	7.97e-05	0.00194	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	7.58e-05	0.00184	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—RHOA—membranous glomerulonephritis	7.44e-05	0.00181	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PLG—membranous glomerulonephritis	7.24e-05	0.00176	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	7.23e-05	0.00176	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLG—membranous glomerulonephritis	7.16e-05	0.00174	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	7.01e-05	0.0017	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—RHOA—membranous glomerulonephritis	6.57e-05	0.0016	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	6.32e-05	0.00154	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	6.19e-05	0.00151	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	6.01e-05	0.00146	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	5.74e-05	0.00139	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—C3—membranous glomerulonephritis	5.5e-05	0.00134	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCA1—membranous glomerulonephritis	5.46e-05	0.00133	CbGpPWpGaD
Valsartan—ALB—Metabolism—TBXAS1—membranous glomerulonephritis	5.43e-05	0.00132	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOE—membranous glomerulonephritis	5.35e-05	0.0013	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOA1—membranous glomerulonephritis	5.29e-05	0.00129	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOE—membranous glomerulonephritis	5.12e-05	0.00125	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOA1—membranous glomerulonephritis	5.07e-05	0.00123	CbGpPWpGaD
Valsartan—ALB—Hemostasis—APOA1—membranous glomerulonephritis	5e-05	0.00122	CbGpPWpGaD
Valsartan—ALB—Metabolism—LRP2—membranous glomerulonephritis	4.84e-05	0.00118	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLA2G1B—membranous glomerulonephritis	4.66e-05	0.00113	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	4.61e-05	0.00112	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	4.56e-05	0.00111	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TBXAS1—membranous glomerulonephritis	4.45e-05	0.00108	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	4.33e-05	0.00105	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—membranous glomerulonephritis	4.19e-05	0.00102	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LRP2—membranous glomerulonephritis	3.96e-05	0.000964	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RHOA—membranous glomerulonephritis	3.88e-05	0.000943	CbGpPWpGaD
Valsartan—ALB—Hemostasis—RHOA—membranous glomerulonephritis	3.83e-05	0.000932	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLA2G1B—membranous glomerulonephritis	3.82e-05	0.000928	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	3.77e-05	0.000917	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	3.73e-05	0.000907	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOE—membranous glomerulonephritis	3.59e-05	0.000874	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOA1—membranous glomerulonephritis	3.55e-05	0.000864	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCA1—membranous glomerulonephritis	3.12e-05	0.000759	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP9—membranous glomerulonephritis	3.08e-05	0.000749	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	2.95e-05	0.000718	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—membranous glomerulonephritis	2.81e-05	0.000684	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCA1—membranous glomerulonephritis	2.55e-05	0.000621	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOE—membranous glomerulonephritis	2.05e-05	0.000499	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOA1—membranous glomerulonephritis	2.03e-05	0.000493	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOE—membranous glomerulonephritis	1.68e-05	0.000409	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOA1—membranous glomerulonephritis	1.66e-05	0.000404	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—membranous glomerulonephritis	1.32e-05	0.00032	CbGpPWpGaD
